KT&G (033780) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Jun, 2026Executive summary
Achieved record quarterly and nine-month operating profit and revenue, driven by robust global CC and tobacco business growth, as well as improved next-generation products (NGP) performance.
Global conventional cigarettes (CC) posted record-high performance for three consecutive quarters, with double-digit growth in both volume (+12.9%) and average selling price (+10.7%).
Consolidated sales for the first nine months of 2025 rose 11.8% year-over-year to KRW 4,865.9 billion, with operating income at KRW 1,100.7 billion and net income at KRW 818.2 billion.
Strategic partnerships and joint acquisitions, including with Altria and Another Snus Factory, to expand the nicotine pouch business globally from 2026.
Maintained a robust financial position, with total assets of KRW 14,779.2 billion and equity of KRW 9,168.0 billion as of September 30, 2025.
Financial highlights
Q3 consolidated revenue rose 11.6% year-over-year to KRW 1.83 trillion, with operating profit up 11.4% to KRW 465.3 billion.
Net income surged 73.4% year-over-year to KRW 418.7 billion, and EPS climbed 81.7% to KRW 3,898.
EBITDA grew 12.3% to KRW 540.5 billion, with a margin of 29.6%.
Tobacco segment sales grew 14.4% year-over-year to KRW 3,310.8 billion, maintaining a domestic market share of 68.1%.
Health functional foods sales declined 8.6% to KRW 894.8 billion, while real estate sales surged 74.1% to KRW 390.3 billion.
Outlook and guidance
Full-year 2025 revenue and operating profit guidance raised to anticipate double-digit growth year-over-year, reflecting strong global market momentum.
Plans for global expansion of nicotine pouch business beyond Nordics into Western Europe, Middle East, Africa, Asia, and North America starting next year.
Ongoing investments in production capacity, digital transformation, and a minimum annual dividend target of KRW 6,000 per share through 2027.
Latest events from KT&G
- Record FY24 results with global growth, higher dividends, and aggressive buybacks.033780
Q4 202424 Jun 2026 - Q2 profit jumped on global tobacco gains, but 2024 outlook was cut as HFF and real estate lagged.033780
Q2 202424 Jun 2026 - Record tobacco growth and shareholder returns offset declines in net income and real estate.033780
Q3 202424 Jun 2026 - Q1 2025 revenue up 15.4% YoY, strong profit growth, and ongoing share buybacks.033780
Q1 202524 Jun 2026 - Record revenue and operating profit growth, but net income fell; dividends and buybacks increased.033780
Q2 202524 Jun 2026 - Record Q1 revenue and profit growth driven by global tobacco and health foods, with stronger dividends ahead.033780
Q1 202622 Jun 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026 - Accelerated global growth, record shareholder returns, and new Altria partnership drive expansion.033780
Investor Day 2025 Presentation23 Sep 2025